{"name":"LyGenesis, Inc.","slug":"lygenesis-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxNSV9jVGRoMVlWT2hsTlRQaDNuekdhZEt3RjF1T0dndERQRXhmUWtVQ09vWWdTTmtqaE4tQndKWW50dkJCcmtlNUJfYnBYTDFsTnhWNWxEVTJPWHY4bi1oMDNZWlZBMDBYTTIzSFE4a1loQlAzRlBXRzJfQnNyNEhMUzlrUDlHY3IzeXE5VjVVSHEtenBWcTEzS2ItcTRlX21Id21sU3RBX2V0Q3lWcndiMFRjWUVBYWw5RGR3X3prVldsenNqVTdqdzltMERLeEpOdURGdWJYNkJjTlhaZ3ZrZU0tZW5BUVh6VUQ5Y2ZQZDBCZm81Q056elF6cTBndjlZRGp5ZURLTnhJZlFqeFJQeldoekdDLXN0bmtINF9KcS16RDMyXzBpT3ZwYVFKNzJLTDVHYW54SFczdw?oc=5","date":"2024-04-02","type":"trial","source":"PR Newswire","summary":"LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease - PR Newswire","headline":"LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbWdKMlY0QVhWcnJiTHpIOHg4a3NlakdUdkY4U0Q4bGxGbUpXbm41UVFpeTVvX3hnV3pCNDEyVVc0UWNIYTJJYmxyLVR3ZUZ0c0JMTk5ubS1URnZPVWpmU3lNMUhFRGtWRjlWa1F6c184OFpUSVdlN0E2Y2ZxRGxxRHYyaFd4aDVMTVRsNEQ3WHpBRXgzMld4dnVPQWxwYzR2LXE0TDR2RVVNc2U4SXJnV3A5SkU5M2E4YlVYbE81QQ?oc=5","date":"2023-10-24","type":"pipeline","source":"PR Newswire","summary":"LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab - PR Newswire","headline":"LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNZzUyeklzSnA1d29LanJnYllNakRFUmluZTVjOEMteW9SU1pza1ZLc0F1bEJRZlM5QXpCamhucUhvTk5WY3cwTkdFRWRZVnJhUEtfUVozMkJWODR3MkQ0RUtEeU8wZUJLc0FTeXF3Rk5qMXdwUFh3V1ViT2tuRVBFTzNHZ3JvMFlnZWY4YXozMER4X0Y0d3JtTU4zblJPd1oxZVpLSGZVWmtndmhLZjJkVndsSmV5Y19uWHFFcVA5OHFFRjl3T3UxZGVnZU5zbE5rQjJ3NHo4eTZxZHM1czR4aVdqd0NBZkMta19LNjVYaXZvSmhRaTNPQ3lodTFBVzg?oc=5","date":"2023-04-11","type":"deal","source":"Pittsburgh Post-Gazette","summary":"Here's why 2 Pittsburgh biotechs inked a research partnership - Pittsburgh Post-Gazette","headline":"Here's why 2 Pittsburgh biotechs inked a research partnership - Pittsburgh Post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOeUY1N1RuVHkybWRqdWprTktCMGtReTU0dGNDeHVUdVpocTFSRnN4ZTVRQVNJSFlQeW16QmJCaWhPbEhqTG5TeF9IRzdLSFZFcGJtemgyT3R5eXlmbXdOWVJBMllaTExKMGJOaXd3ZVpGYkxqcGhadndBTVBVTko5VkdOWFl1V1dXa1NqQXlVN2c1Zkg2NndBS1JGY3JHaU96UjhOZ0UzY3JYdGJQemo3Uy1rRDR1WUlHdVE?oc=5","date":"2021-07-23","type":"deal","source":"Business Wire","summary":"AgeX Therapeutics and LyGenesis Terminate Merger Negotiations - Business Wire","headline":"AgeX Therapeutics and LyGenesis Terminate Merger Negotiations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOVUphU1l2S2lMM0ZIUFVtQnItNGRyYklPWVlwa1RXNEtORExIcXdIMXUzWFdMal93Nmw4M1JEZDhYY1FWUlIzYy1nVWpsUFpSS1htMzlVTEI5TFpTSVBOUE1QMHQtbHRfUTQyRWNNR2ltWG1HZUVESl8wNjVuTUlyY1lsS3hncC1tOE1KX2NVamh5UjJuUldkRENVbE5yeEY3VmVqU0pkYzBrbXJ1YUxmcnFTanFvTzNFcy0yMHQ4N3hCRWRnc3dpQVVVaDRjZTFYeV9NMENDczRZcUNxNWUxclRkMUpvdmVqS2IzMnJMc3JuQQ?oc=5","date":"2018-05-09","type":"pipeline","source":"PR Newswire","summary":"LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic - PR Newswire","headline":"LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}